Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 4
1952 2
1953 1
1954 6
1955 12
1956 6
1957 3
1958 23
1959 13
1960 9
1961 14
1962 16
1963 24
1964 18
1965 28
1966 33
1967 32
1968 35
1969 42
1970 43
1971 61
1972 50
1973 49
1974 48
1975 48
1976 48
1977 71
1978 59
1979 77
1980 75
1981 67
1982 89
1983 78
1984 81
1985 78
1986 105
1987 110
1988 123
1989 134
1990 121
1991 121
1992 142
1993 133
1994 124
1995 119
1996 131
1997 171
1998 159
1999 173
2000 227
2001 238
2002 213
2003 257
2004 270
2005 294
2006 294
2007 314
2008 319
2009 371
2010 383
2011 439
2012 440
2013 459
2014 423
2015 455
2016 453
2017 453
2018 473
2019 462
2020 514
2021 540
2022 566
2023 569
2024 279
2025 1

Text availability

Article attribute

Article type

Publication date

Search Results

11,712 results

Results by year

Filters applied: . Clear all
Page 1
Updated guidelines for chronic active Epstein-Barr virus disease.
Kawada JI, Ito Y, Ohshima K, Yamada M, Kataoka S, Muramatsu H, Sawada A, Wada T, Imadome KI, Arai A, Iwatsuki K, Ohga S, Kimura H; Committee for Guidelines for the Management of Chronic Active EBV Disease, Related Disorders (the MHLW Research Team in Japan). Kawada JI, et al. Among authors: ito y. Int J Hematol. 2023 Nov;118(5):568-576. doi: 10.1007/s12185-023-03660-5. Epub 2023 Sep 20. Int J Hematol. 2023. PMID: 37728704 Free PMC article. Review.
A risk-based subgroup analysis of the effect of adjuvant S-1 in estrogen receptor-positive, HER2-negative early breast cancer.
Takada M, Imoto S, Ishida T, Ito Y, Iwata H, Masuda N, Mukai H, Saji S, Ikeda T, Haga H, Saeki T, Aogi K, Sugie T, Ueno T, Ohno S, Ishiguro H, Kanbayashi C, Miyamoto T, Hagiwara Y, Toi M. Takada M, et al. Among authors: ito y. Breast Cancer Res Treat. 2023 Dec;202(3):485-496. doi: 10.1007/s10549-023-07099-4. Epub 2023 Sep 7. Breast Cancer Res Treat. 2023. PMID: 37676450 Free PMC article.
Long-Term Outcomes of Active Surveillance and Immediate Surgery for Adult Patients with Low-Risk Papillary Thyroid Microcarcinoma: 30-Year Experience.
Miyauchi A, Ito Y, Fujishima M, Miya A, Onoda N, Kihara M, Higashiyama T, Masuoka H, Kawano S, Sasaki T, Nishikawa M, Fukata S, Akamizu T, Ito M, Nishihara E, Hisakado M, Kosaka K, Hirokawa M, Hayashi T. Miyauchi A, et al. Among authors: ito y. Thyroid. 2023 Jul;33(7):817-825. doi: 10.1089/thy.2023.0076. Epub 2023 May 29. Thyroid. 2023. PMID: 37166389 Free PMC article.
Inter- and intra-tumor heterogeneity of genetic and immune profiles in inherited renal cell carcinoma.
Tabata M, Sato Y, Kogure Y, McClure MB, Oshikawa-Kumade Y, Saito Y, Shingaki S, Ito Y, Yuasa M, Koya J, Yoshida K, Kohno T, Miyama Y, Morikawa T, Chiba K, Okada A, Ogawa S, Ushiku T, Shiraishi Y, Kume H, Kataoka K. Tabata M, et al. Among authors: ito y. Cell Rep. 2023 Jul 25;42(7):112736. doi: 10.1016/j.celrep.2023.112736. Epub 2023 Jul 4. Cell Rep. 2023. PMID: 37405915 Free article.
11,712 results
You have reached the last available page of results. Please see the User Guide for more information.